Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of antidiabetic drugs. It serves as a chiral building block for dipeptidyl peptidase-4 (DPP-4) inhibitors, which are employed in the treatment of type 2 diabetes. Its stereochemistry enables high selectivity and potency in drug formulations, contributing to improved metabolic stability and prolonged therapeutic effect. Commonly utilized in active pharmaceutical ingredient (API) manufacturing for oral hypoglycemic agents.